HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand.

AbstractOBJECTIVES:
To evaluate the carotid intima-media thickness (cIMT) in perinatally HIV-infected adolescents and factors associated with cardiovascular abnormalities.
DESIGNS:
A cross-sectional study was conducted in perinatally HIV-infected adolescents who had no known cardiovascular condition and healthy controls.
METHODS:
Transthoracic echocardiogram and cIMT measurements were taken by pediatric cardiologists. Serum lipid profiles, high-sensitivity C-reactive protein and N-terminal pro-brain natriuretic peptide were measured.
RESULTS:
Hundred HIV-infected and 50 healthy adolescents were enrolled. Echocardiograms revealed overall normal systolic function (median left-ventricular ejection fraction 66 vs. 66%; P = 0.825). The mean overall cIMTs of common carotid arteries and internal carotid arteries were not different between the groups (0.373 vs. 0.371; P = 0.744). Among the HIV-infected adolescents, those who had been receiving protease inhibitor-containing regimens had an increased cIMT (0.364 vs. 0.381 mm; P = 0.009). Hypertriglyceridemia was found in 52% of those who had received protease inhibitors for more than 6 months, but only in 21% of those who had never received protease inhibitors (odds ratio 4.0, 95% confidence interval 1.6-9.7, P = 0.002). Current HIV-RNA, CD4, BMI, sex, cholesterol and low-density lipoprotein-cholesterol were not associated with increased cIMT. Serum high-sensitivity C-reactive protein and N-terminal pro-brain natriuretic peptide were not different between the groups and not associated with cardiac abnormalities.
CONCLUSIONS:
Perinatally HIV-infected adolescents had comparable myocardial function and similar cIMT measurements to healthy adolescents. However, hypertriglyceridemia and increased cIMT were found in HIV-infected adolescents receiving protease inhibitor-based regimens. Longer-term follow-up is needed to evaluate HIV-associated cardiovascular disease risk in this population.
AuthorsPrakul Chanthong, Keswadee Lapphra, Supawan Saihongthong, Sirintip Sricharoenchai, Orasri Wittawatmongkol, Wanatpreeya Phongsamart, Supattra Rungmaitree, Nantaka Kongstan, Kulkanya Chokephaibulkit
JournalAIDS (London, England) (AIDS) Vol. 28 Issue 14 Pg. 2071-9 (Sep 10 2014) ISSN: 1473-5571 [Electronic] England
PMID25265075 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Lipids
  • Peptide Fragments
  • Triglycerides
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • C-Reactive Protein
Topics
  • Adolescent
  • Antiretroviral Therapy, Highly Active
  • C-Reactive Protein (metabolism)
  • Carotid Intima-Media Thickness
  • Child
  • Cross-Sectional Studies
  • Echocardiography
  • Female
  • HIV Infections (blood, pathology)
  • Humans
  • Lipids (blood)
  • Male
  • Natriuretic Peptide, Brain (blood)
  • Peptide Fragments (blood)
  • Prospective Studies
  • Risk Factors
  • Thailand (epidemiology)
  • Triglycerides (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: